Join to View Full Profile
725 Welch RdPalo Alto, CA 94304
Phone+1 650-497-8000
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anne Borgman, MD is a pediatric hematologist/oncologist in Palo Alto, California. She is currently licensed to practice medicine in California, Illinois, and Texas.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1997 - 2000
Baylor College of Medicine (Houston)Residency, Pediatrics, 1994 - 1997
Loyola University Chicago Stritch School of MedicineClass of 1994- Loyola University Chicago Stritch School of MedicineClass of 1994
Certifications & Licensure
IL State Medical License 2000 - 2026
CA State Medical License 1997 - 2024
TX State Medical License 1996 - 1997
Publications & Presentations
PubMed
- 28 citationsPharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function.Agop Y. Bedikian, Jeffrey A. Silverman, Nicholas E. Papadopoulos, Kevin B. Kim, Anne E. Hagey
Journal of Clinical Pharmacology. 2011-08-01 - 15 citationsIncreasing diversity in pediatric hematology/oncology.Ernest Frugé, Joan M. Lakoski, Naomi L.C. Luban, Jeffrey M. Lipton, David G. Poplack
Pediatric Blood & Cancer. 2011-07-15 - 61 citationsA phase II study of ABT-751 in patients with advanced non-small cell lung cancer.Ann M. Mauer, Ezra E.W. Cohen, Patrick C. Ma, Mark Kozloff, Lee S. Schwartzberg
Journal of Thoracic Oncology. 2008-06-01
Press Mentions
Sutro Biopharma Announces Initiation of the Registration-Enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AMLNovember 1st, 2024
Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung CancerAugust 22nd, 2024- NiKang Therapeutics Appoints Anne E. Borgman, M.D., to Board of DirectorsJanuary 18th, 2023
- Join now to see all
